The nitrogen mustards are powerful cytotoxic and lymphoablative agents and have been
used for more than 60 years. They are employed in the treatment of cancers, sarcomas, and …

Lacrimal gland tumors are rare and constitute a wide spectrum of different entities ranging
from benign epithelial and lymphoid lesions to high-grade carcinomas, lymphomas, and …

The management of patients with relapsed or refractory follicular lymphoma has evolved
markedly in the last decade, with the availability of new classes of agents (phosphoinositide …

Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a
chronic, relapsing, indolent condition with long overall survival (OS). Most people affected …

We assessed stage-specific trends in primary therapy and relative survival among adult
follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N …

Progression of disease within 24 months (POD24) is strongly associated with a poor
outcome in patients with follicular lymphoma (FL). Our study aimed to identify the potential …

Introduction: In recent years, the prognosis for low-grade lymphoma in the ocular region has
improved markedly, whereas high-grade lymphoma is still a challenging disease to manage …

Background: In spite of increasing number of chemotherapeutic drugs, achieving
chemotherapy drug with minimal side effects in cancer treatment is still a major challenge …

Lacrimal gland tumors are rare, with an estimated incidence of 1 per 1 million people per
year in Denmark. 1 The proportion of orbital spaceoccupying lesions represented by …

The outcome of patients with follicular lymphoma has substantially improved in recent years,
mainly due to the widespread use of the monoclonal antibody rituximab and partially due to …